Skip to main content

Advertisement

Log in

Experiences of gout-related disability from the patients’ perspective: a mixed methods study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Disability is a common problem in patients with gout. Recently, the Health Assessment Questionnaire Disability Index (HAQ-DI) was recommended for assessing patient-reported activity limitations in gout. However, few studies have explored experiences and issues of disability from the perspective of gout patients themselves. The objectives of this study were to explore disability issues in patients with gout and to examine the content validity of the HAQ-DI in this patient group. Two studies were performed: a semi-structured interview study with seven male gout patients and a cross-sectional survey study among 34 other patients with gout. In both studies, specific examples of activity limitations were elicited using open-ended methods. The survey study additionally aimed to quantify the relevance of the activities listed in the HAQ-DI. Most patients experienced several gout attacks in the previous year. Limitations were reported to occur during a flare, but patients were generally not limited between attacks. During an attack, patients mainly experienced limitations related to mobility, especially walking and climbing stairs. Patients also mentioned limitations in activities related to domestic life, such as gardening and doing housework. Limitations related to self-care or activities requiring the use of the upper extremities were rarely mentioned. Corresponding HAQ-DI items were skewed towards very low disability scores over the past week. Assessments of gout-related disability should particularly focus on mobility and lower extremity functioning and should consider the intermittent nature of the disease. The HAQ-DI may not adequately meet these requirements, suggesting the need to explore other measures of gout-related disability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Smith EU, Diaz-Torne C, Perez-Ruiz F, March LM (2010) Epidemiology of gout: an update. Best Pract Res Clin Rheumatol 24:811–827

    Article  CAS  PubMed  Google Scholar 

  2. Brook RA, Forsythe A, Smeeding JE, Lawrence EN (2010) Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 26:2813–2821

    Article  PubMed  Google Scholar 

  3. ten Klooster PM, Vonkeman HE, van de Laar MA (2012) Disability due to gouty arthritis. Curr Opin Rheumatol 24:139–144

    Article  PubMed  Google Scholar 

  4. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N (2011) The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol 17:1–6

    Article  PubMed  Google Scholar 

  5. Becker MA, Schumacher HR, Benjamin KL et al (2009) Quality of life and disability in patients with treatment-failure gout. J Rheumatol 36:1041–1048

    Article  PubMed  Google Scholar 

  6. Lee SJ, Hirsch JD, Terkeltaub R et al (2009) Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford) 48:582–586

    Article  Google Scholar 

  7. Strand V, Crawford B, Singh J, Choy E, Smolen JS, Khanna D (2009) Use of “spydergrams” to present and interpret SF-36 health-related quality of life data across rheumatic diseases. Ann Rheum Dis 68:1800–1804

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Schumacher HR Jr, Edwards LN, Perez-Ruiz F et al (2005) Outcome measures for acute and chronic gout. J Rheumatol 32:2452–2455

    PubMed  Google Scholar 

  9. Schumacher HR, Taylor W, Edwards L et al (2009) Outcome domains for studies of acute and chronic gout. J Rheumatol 36:2342–2345

    Article  PubMed  Google Scholar 

  10. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145

    Article  CAS  PubMed  Google Scholar 

  11. Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178

    PubMed  Google Scholar 

  12. Singh JA, Taylor WJ, Simon LS et al (2011) Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol 38:1452–1457

    Article  PubMed  Google Scholar 

  13. Kalyoncu U, Dougados M, Daures JP, Gossec L (2009) Reporting of patient-reported outcomes in recent trials in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 68:183–190

    Article  CAS  PubMed  Google Scholar 

  14. Oude Voshaar MA, ten Klooster PM, Taal E, van de Laar MA (2011) Measurement properties of physical function scales validated for use in patients with rheumatoid arthritis: a systematic review of the literature. Health Qual Life Outcomes 9:99

    Article  PubMed Central  PubMed  Google Scholar 

  15. Prowse RL, Dalbeth N, Kavanaugh A et al (2013) A Delphi exercise to identify characteristic features of gout - opinions from patients and physicians, the first stage in developing new classification criteria. J Rheumatol 40:498–505

    Article  PubMed  Google Scholar 

  16. ten Klooster PM, Oude Voshaar MA, Taal E, van de Laar MA (2011) Comparison of measures of functional disability in patients with gout. Rheumatology (Oxford) 50:709–713

    Article  Google Scholar 

  17. Alvarez-Hernandez E, Pelaez-Ballestas I, Vazquez-Mellado J et al (2008) Validation of the Health Assessment Questionnaire disability index in patients with gout. Arthritis Rheum 59:665–669

    Article  PubMed  Google Scholar 

  18. Khanna D, Ahmed M, Yontz D et al (2008) The disutility of chronic gout. Qual Life Res 17:815–822

    Article  PubMed  Google Scholar 

  19. Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N (2008) The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout. Clin Exp Rheumatol 26:620–626

    CAS  PubMed  Google Scholar 

  20. McPherson KM, Brander P, Taylor WJ, McNaughton HK (2001) Living with arthritis—what is important? Disabil Rehabil 23:706–721

    Article  CAS  PubMed  Google Scholar 

  21. Liedberg GM, Henriksson CM (2002) Factors of importance for work disability in women with fibromyalgia: an interview study. Arthritis Rheum 47:266–274

    Article  PubMed  Google Scholar 

  22. Boonen A, van Berkel M, Cieza A, Stucki G, van der Heijde D (2009) Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews. J Rheumatol 36:2501–2511

    Article  PubMed  Google Scholar 

  23. Nikolaus S, Bode C, Taal E, van de Laar MA (2010) New insights into the experience of fatigue among patients with rheumatoid arthritis: a qualitative study. Ann Rheum Dis 69:895–897

    Article  PubMed  Google Scholar 

  24. Hewlett S, Sanderson T, May J et al (2012) ‘'I’m Hurting, I want to kill myself’: rheumatoid arthritis flare is more than a high joint count—an international patient perspective on flare where medical help is sought. Rheumatology (Oxford) 51:69–76

    Article  Google Scholar 

  25. Hewlett S, Smith AP, Kirwan JR (2001) Values for function in rheumatoid arthritis: patients, professionals, and public. Ann Rheum Dis 60:928–933

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Hewlett S, Carr M, Ryan S et al (2005) Outcomes generated by patients with rheumatoid arthritis: how important are they? Musculoskeletal Care 3:131–142

    Article  PubMed  Google Scholar 

  27. ten Klooster PM, Veehof MM, Taal E, van Riel PL, van de Laar MA (2007) Changes in priorities for improvement in patients with rheumatoid arthritis during 1 year of anti-tumour necrosis factor treatment. Ann Rheum Dis 66:1485–1490

    Article  PubMed Central  PubMed  Google Scholar 

  28. WHO (2001) International classification of functioning, disability and health: ICF. World Health Organization, Geneva

    Google Scholar 

  29. Räty S, Aromaa A, Koponen P. (2003) Measurement of physical functioning in comprehensive national healt surveys - ICF as a framework: National Public Health Institute, KTL

  30. Cieza A, Brockow T, Ewert T et al (2002) Linking health-status measurements to the international classification of functioning, disability and health. J Rehabil Med 34:205–210

    Article  PubMed  Google Scholar 

  31. Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustun B, Stucki G (2005) ICF linking rules: an update based on lessons learned. J Rehabil Med 37:212–218

    Article  PubMed  Google Scholar 

  32. Boonen A, Stucki G, Maksymowych W, Rat AC, Escorpizo R, Boers M (2009) The OMERACT-ICF reference group: integrating the ICF into the OMERACT process: opportunities and challenges. J Rheumatol 36:2057–2060

    Article  PubMed  Google Scholar 

  33. Jette AM (2006) Toward a common language for function, disability, and health. Phys Ther 86:726–734

    Article  PubMed  Google Scholar 

  34. Martin ML, Patrick DL, Gandra SR et al (2011) Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia. Qual Life Res 20:889–901

    Article  PubMed  Google Scholar 

  35. Boers M, Jacobs JW, van Vliet Vlieland TP, van Riel PL (2007) Consensus Dutch Health Assessment Questionnaire. Ann Rheum Dis 66:132–133

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Bryman A, Burgess R (1994) Analysing qualitative data. Routledge, London

    Book  Google Scholar 

  37. Pope C, Ziebland S, Mays N (2000) Qualitative research in health care. Analysing qualitative data. BMJ 320:114–116

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  38. Fayers PM, Machin D (2007) Scores and measurements: validity, reliability, sensitivity. In: Fayers PM, Machin D (eds) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes, 2nd edn. Wiley, Chichester, pp 77–108

    Chapter  Google Scholar 

  39. Mokkink LB, Terwee CB, Patrick DL et al (2010) The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 63:737–745

    Article  PubMed  Google Scholar 

  40. Patrick DL, Burke LB, Gwaltney CJ et al (2011) Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2—assessing respondent understanding. Value Health 14:978–988

    Article  PubMed  Google Scholar 

  41. Haynes SN, Richard D, Kubany ES (1995) Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess 7:238

    Article  Google Scholar 

  42. FDA. (2009) Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. US Food and Drug Administration

  43. Stull DE, Leidy NK, Parasuraman B, Chassany O (2009) Optimal recall periods for patient-reported outcomes: challenges and potential solutions. Curr Med Res Opin 25:929–942

    Article  PubMed  Google Scholar 

  44. Colwell HH, Hunt BJ, Pasta DJ, Palo WA, Mathias SD, Joseph-Ridge N (2006) Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness. Int J Clin Pract 60:1210–1217

    Article  CAS  PubMed  Google Scholar 

  45. Hirsch JD, Lee SJ, Terkeltaub R et al (2008) Evaluation of an instrument assessing influence of gout on health-related quality of life. J Rheumatol 35:2406–2414

    Article  PubMed  Google Scholar 

  46. Khanna D, Sarkin AJ, Khanna PP et al (2011) Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford) 50:1331–1336

    Article  Google Scholar 

  47. Wolfe F, Michaud K, Pincus T (2004) Development and validation of the Health Assessment Questionnaire II: a revised version of the Health Assessment Questionnaire. Arthritis Rheum 50:3296–3305

    Article  PubMed  Google Scholar 

  48. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  49. Solomon DH, Avorn J, Levin R, Brookhart MA (2008) Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis 67:609–613

    Article  CAS  PubMed  Google Scholar 

  50. Dalbeth N, House ME, Horne A et al (2013) The experience and impact of gout in Maori and pacific people: a prospective observational study. Clin Rheumatol 32:247–251

    Article  PubMed  Google Scholar 

  51. Fries JF, Bruce B, Bjorner J, Rose M (2006) More relevant, precise, and efficient items for assessment of physical function and disability: moving beyond the classic instruments. Ann Rheum Dis 65(Suppl 3):iii16–iii21

    PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Lukas Lange for performing and transcribing the interviews.

Disclosures

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter M. ten Klooster.

Rights and permissions

Reprints and permissions

About this article

Cite this article

ten Klooster, P.M., Vonkeman, H.E., Oude Voshaar, M.A.H. et al. Experiences of gout-related disability from the patients’ perspective: a mixed methods study. Clin Rheumatol 33, 1145–1154 (2014). https://doi.org/10.1007/s10067-013-2400-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-013-2400-6

Keywords

Navigation